ConductScience.org, home

Paper27273168

The role of the gut microbiota in NAFLD.

Leung C and 3 others. Nat Rev Gastroenterol Hepatol, 2016. Cited by 829 papers, by iCite.

Cite this record

ConductScience Library. The role of the gut microbiota in NAFLD. Papers, record 27273168. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27273168

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of the gut microbiota in NAFLD.
PubMed
Journal
Nat Rev Gastroenterol Hepatol
PubMed
Year
2016
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
829
iCite
Relative citation ratio, by iCite
32.1
iCite
Revised in PubMed
2022-04-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leung CChristopher
2Rivera LLeni
3Furness JBJohn B
4Angus PWPeter W

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastrointestinal MicrobiomeMajor topic
Non-alcoholic Fatty Liver DiseaseMajor topic
Bile Acids and Salts
Diet
Disease Progression
Ethanol
Exercise
Fatty Acids, Volatile
Fungi
Gastrointestinal Motility
Glucose
Gram-Negative Bacteria
Gram-Positive Bacteria
Host-Pathogen Interactions
Humans
Intestines
Liver
Methylamines
Permeability
Phosphatidylcholines
Prebiotics
Probiotics
Receptors, G-Protein-Coupled
Sleep
Viruses

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04671186Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With FibroscanBackgroundClinicalTrials.gov
NCT06682663Impact of Live Streaming Exercise on Liver Health in MASLD Pregnant WomenBackgroundClinicalTrials.gov
NCT07857941Exploring Novel Therapeutic Approaches for Disorders of Gut-Liver-Brain Interaction-H1/H2BackgroundClinicalTrials.gov

Download CSV of trials

References187

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124372861Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis.J Gastroenterol Hepatol2014https://conductscience.org/library/papers/24372861PubMed
215640457Temporal pattern of de novo lipogenesis in the postprandial state in healthy men.Am J Clin Nutr2005https://conductscience.org/library/papers/15640457PubMed
324226770Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.Nature2013https://conductscience.org/library/papers/24226770PubMed
425957914Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.Int J Biochem Cell Biol2015https://conductscience.org/library/papers/25957914PubMed
524508599Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities.Gastroenterology2014https://conductscience.org/library/papers/24508599PubMed
623551139Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses.FEMS Microbiol Lett2013https://conductscience.org/library/papers/23551139PubMed
725564811Overstated associations between fructose and nonalcoholic fatty liver disease.J Pediatr Gastroenterol Nutr2015https://conductscience.org/library/papers/25564811PubMed
819645728Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.Alcohol Clin Exp Res2009https://conductscience.org/library/papers/19645728PubMed
923850261Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements.Trends Endocrinol Metab2013https://conductscience.org/library/papers/23850261PubMed
1016895997Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16895997PubMed
1112604787Origin and evolution of circadian clock genes in prokaryotes.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12604787PubMed
1223727264Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.Gastroenterology2013https://conductscience.org/library/papers/23727264PubMed
1322686435Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity.Obes Rev2012https://conductscience.org/library/papers/22686435PubMed
1418762021Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice.Cell Metab2008https://conductscience.org/library/papers/18762021PubMed
1525326801Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production.Nat Med2014https://conductscience.org/library/papers/25326801PubMed
1623396737Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study.Ann Hepatol2013https://conductscience.org/library/papers/23396737PubMed
1725466902Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.FASEB J2015https://conductscience.org/library/papers/25466902PubMed
1810222383Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine.J Nutr1999https://conductscience.org/library/papers/10222383PubMed
1925021423Exercise and associated dietary extremes impact on gut microbial diversity.Gut2014https://conductscience.org/library/papers/25021423PubMed
2025625278Implication of gut microbiota in nonalcoholic fatty liver disease.PLoS Pathog2015https://conductscience.org/library/papers/25625278PubMed

See all 187 referencesDownload CSV of references

Cited by549

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 829 citations.

PMIDTitleJournalYearIn PapersSource
42948719Gut-liver axis and intestinal microbiota: Key targets of herbal medicines in treatment of MASLD/MASH.Chin Herb Med2026https://conductscience.org/library/papers/42948719PubMed
42947233Dietary-fibre intake, genetic factors, and the risk of nonalcoholic fatty liver disease: a prospective study in the UK Biobank.Hum Genomics2026https://conductscience.org/library/papers/42947233PubMed
42943735Oleanolic Acid-Loaded Cyclodextrin Metal-Organic Framework Ameliorates NAFLD via Modulation of Gut Microbiota and Liver Metabolism.Molecules2026https://conductscience.org/library/papers/42943735PubMed
42939828Gut Microbiota-Host Redox Crosstalk: Molecular Mechanisms, Disease Pathogenesis, and Therapeutic Interventions.Antioxidants (Basel)2026https://conductscience.org/library/papers/42939828PubMed
42895196Acute liver injury is triggered by dysbiosis and microbial translocation involving gut-liver axis.Gut Microbes2026https://conductscience.org/library/papers/42895196PubMed
42666665Mapping GLP-1 receptor agonist research across the MASLD-MASH-HCC continuum: a bibliometric and translational analysis.Front Med (Lausanne)2026https://conductscience.org/library/papers/42666665PubMed
42662117Gut microbiota and the gut-liver axis in MASLD: mechanisms, immune regulation and therapeutic opportunities.Front Pharmacol2026https://conductscience.org/library/papers/42662117PubMed
42646322Therapeutic Mechanisms of Resmetirom and Semaglutide in MASLD/MASH: A Review of Inflammatory and Fibrotic Metabolites.Metabolites2026https://conductscience.org/library/papers/42646322PubMed
42596894Associations between physical activity and dietary live microbe intake with non-alcoholic fatty liver disease: findings from the NHANES, 2007-2018.J Glob Health2026https://conductscience.org/library/papers/42596894PubMed
42588152The MASLD-Cardio-Oncology Triangle: Dietary Patterns, Metabolic Remodelling and Implications for Cancer Therapy Tolerance.Nutrients2026https://conductscience.org/library/papers/42588152PubMed
42572438Polyphenols as Systems Modulators of the Gut-Brain-Liver Axis: A Narrative Review of Neuro-Metabolic and Immunomodulatory Networks.Mol Nutr Food Res2026https://conductscience.org/library/papers/42572438PubMed
42528697Lipid-derived microbial metabolites at the gut-liver interface: regulation of intestinal barrier function, immune signaling, and metabolic inflammation.Front Physiol2026https://conductscience.org/library/papers/42528697PubMed
42471327Sheep-derived probiotics alleviate weaning-induced oxidative stress in lambs via the gut-liver axis.NPJ Biofilms Microbiomes2026https://conductscience.org/library/papers/42471327PubMed
42451149MELHAC Improves Glucose and Lipid Metabolism in HFD + Alloxan-Induced Mice.Nutrients2026https://conductscience.org/library/papers/42451149PubMed
42435168Gut-Liver Microbiome and Tumor Microenvironment in Metabolic Dysfunction-Associated Steatotic Liver Disease.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435168PubMed
42428317Herbal medicines modulate gut microbiota in metabolic diseases: a review.Front Microbiol2026https://conductscience.org/library/papers/42428317PubMed
42423485The Role of Gut Microbiota in Liver Regeneration After Partial Hepatectomy: New Evidence From Animal and Human Studies.FASEB J2026https://conductscience.org/library/papers/42423485PubMed
42370351The current status and emerging trends in the application of precision nutrition for the comprehensive, lifecycle-based management of chronic liver diseases.Front Nutr2026https://conductscience.org/library/papers/42370351PubMed
42351186Dynamic gut microbiota shift in chronic liver disease progression: machine learning models and the E/Er ratio as a predictive biomarker.J Transl Med2026https://conductscience.org/library/papers/42351186PubMed
42330353Chronic infection and metabolic stress: a converging axis driving hypertension and metabolic dysfunction-associated steatotic liver disease outcomes.Am J Hypertens2026https://conductscience.org/library/papers/42330353PubMed

See all 549 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27273168

GET https://conductscience.org/api/papers/v1/27273168/references?page=2